Correlation Between State-Trait-Anxiety-Inventory and Heart Rate Variability

Correlation Between State-Trait-Anxiety-Inventory and Heart Rate Variability: An Observational Cohort and Pilot Study

The purpose of the study is to investigate whether there is a correlation between the vegetative stress evaluated by the State-Trait-Anxiety-Inventory (STAI-Test) and the measurement of heart rate variability (HRV). A subgroup analysis will also be performed to determine whether premedication contributes to a lower STAI score and/or heart rate variability. The primary outcome will be the parameter of frequency-based analysis Low Frequency (LF) and High Frequency (HF), and the STAI score. Secondary outcomes are the parameters Low Frequency/High Frequency-ratio (LF/HF-ratio), Standard deviation of normal-to-normal (NN) intervals (SDNN), Root Mean Square of successive differences" (RMSSD) and mean heart rate, age, gender, if they are smokers and if they work in shifts.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salzburg, Austria, 5020
        • Allgemeine Unfallversicherungsanstalt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The subjects are recruited after the anesthesia interview with the anesthesiologist.

anesthesiologist. Subjects with elective surgery associated with a low risk of bleeding will be included. This includes procedures such as knee arthroplasties, cruciate ligamentoplasties, or metal removals.

Description

Inclusion Criteria:

  • Subjects between 18 and 65 years
  • Elective surgery with a low risk of bleeding
  • American Society of Anesthesiologists (ASA) classification 1-2
  • metabolic equivalent of task (MET) > 4

Exclusion Criteria:

  • Pre-existing cardiac conditions such as heart failure, arterial hypertension,
  • diabetes
  • any central nervous system diseases
  • cardiac pacemaker
  • renal and hepatic insufficiency
  • regional or peridural anesthesia
  • Pregnancy, lactation
  • Drugs that directly influence the autonomic nervous system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State and Trait Anxiety Inventory (STAI-score)
Time Frame: First questionnaire is given 40 minutes before transfer to the holding area and the second questionnaire postoperative in the recovery ward directly before transfer back to ward
STAI: State-Trait-Anxiety-Inventory-Score This test consists of 40 items and assesses the current state of anxiety in relation to the current situation in which the patient is to the current situation in which the patient finds herself (State Anxiety) and the general anxiety state existing state of anxiety, which represents a part of her personality (Trait Anxiety). A score of 20-80 could be achieved, with higher scores correlating with correlated with higher anxiety levels. Accordingly, scores of 20-39, 40-59, and 60-80 would indicate low, moderate, and high anxiety.
First questionnaire is given 40 minutes before transfer to the holding area and the second questionnaire postoperative in the recovery ward directly before transfer back to ward
The measurement method of heart rate variability (especially the parameter of the frequency domain Low Frequency and High Frequency
Time Frame: One measurement (3-6 hours), start of measurement together with the first STAI questionnaire (40 min before transfer to the holding area), end of measurement after the second STAI questionnaire is done.

Low frequency power (LF):

Power density spectrum in the frequency range from 0.04-0.15 Hz

High frequency power (HF):

Power density spectrum in the frequency range from 0.15 to 0.40 Hz

One measurement (3-6 hours), start of measurement together with the first STAI questionnaire (40 min before transfer to the holding area), end of measurement after the second STAI questionnaire is done.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate variability ("Standard deviation of normal-to-normal (NN) intervals" (SDNN) and "Root Mean Square of successive differences" (RMSSD) of the time domain and "LF/HF-ratio" from the frequency domain) as well as mean heart rate
Time Frame: HRV-parameters and mean heart rate were obtained in the same time frame as outcome 2.

Standard deviation of NN-intervals (SDNN):

intervals in the measuring range; NN-intervals refer to the intervals between normal R-peaks in an electrocardiogram

Root Mean Square of successive differences (RMSSD)

Low Frequency/High Frequency-ratio (LF/HF ratio):

Quotient of the spectrum in LF and the spectrum in HF, No clear assignment, Ratio or Coefficient or Ratio between LF-and HF Band power

HRV-parameters and mean heart rate were obtained in the same time frame as outcome 2.
Age, gender, if they are smokers and if they work in shifts
Time Frame: Outcomes will be collected following the routine anaesthesia interview with the anaesthesiologist as part of the recruitment process.

Age: 18-65

Gender: male, female

smoker: no, (never; nonsmoker > 1 year), yes (< 5/d; 6-15/d; >15/d)

working in shifts: yes, no

Outcomes will be collected following the routine anaesthesia interview with the anaesthesiologist as part of the recruitment process.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerhard Fritsch, PD. Dr., Ludwig Boltzmann Institute for Traumatology - The research center in cooperation with AUVA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

October 2, 2023

Study Registration Dates

First Submitted

October 4, 2023

First Submitted That Met QC Criteria

October 17, 2023

First Posted (Actual)

October 23, 2023

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Version 1.2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preoperative Vegetative Stress

Subscribe